Europe should be generics global powerhouse
20/6/2011
The European Generic medicines Association (EGA) noted at their annual conference that, with the global biosimilar and generic medicines markets set to expand significantly over the next 10 years, "it is imperative that Europe acts swiftly on the global stage". More ...
Author: Greer Deal, Director of Global Regulatory Services (GRS)